Saturday Opinion: Without a coherent approach to capturing domestic value from R&D including greater clarity on subject matter patentability, the positive consequences of higher US government funding will be felt as much in Berlin, Bangalore and Beijing as Boston
Despite her caution against reading too much into her rulings, PTAB practitioners are noting patterns and predicting their significance
As the legislation celebrates 10 years, Michael Renaud, Jonathan Engler and Jessica Perry of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo analyse a decade of data to reveal that, far from helping small businesses by improving patent quality, it has only succeeded in driving them out of US district courts.
With the retirement of Patrick Leahy and the overall race too close to call, uncertainty is the name of the game in Washington DC
14 September 2022
Saturday Opinion: The new USPTO director is doing what Congress intended the America Invents Act to do with the post-grant invalidity challenge system it created
10 September 2022
Patent bodies must adapt and evolve to address knowledge gaps in changing digital landscape
09 September 2022
The top court speedily backed an earlier judgment against rights owner Chugai Pharmaceuticals
08 September 2022
Kathi Vidal says the agency is working with NIST and the Biden administration to build strategies that will lead to greater involvement
07 September 2022
The law is in a state of disarray that has led to inconsistent case decisions, deep uncertainty in the innovative, investment and legal communities, and unpredictable outcomes in prosecution and litigation. David Kappos, Paul Michel, Corey Salsberg and Matthew Dowd argue that the United States' legislators must act to ensure the country maintains its long-standing competitive edge in the global innovation race
07 September 2022
A recent judgment from the Delhi High Court emphasises procedural irregularities and denial of principles of natural justice resulting from the controller issuing a non-speaking order in a case involving non-patentable subject matter.
07 September 2022
The Chinese handset maker is seeking to shut down the Finnish company’s base stations
05 September 2022
The company’s October 2020 non-enforcement promise may be a roadblock for its legal action against Pfizer/BioNTech
03 September 2022
Former USPTO Director Andrei Iancu warns that the US is facing “a new Sputnik moment”, but he and others at an online event caution against reading too much into raw numbers
01 September 2022
Unlock unlimited access to all IAM content
